Jane Street Group, LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $2.96 Million - $4.02 Million	462,200 New	462,200 $3.51 Million
Q1 2022 May 17, 2022	SELL	$11.56 - $19.76 $552,568 - $944,528	-47,800 Reduced 17.66%	222,900 $3.62 Million
Q4 2021 Feb 15, 2022	SELL	$11.18 - $15.46 $1.46 Million - $2.02 Million	-130,900 Reduced 32.59%	270,700 $3.75 Million
Q3 2021 Nov 16, 2021	SELL	$14.21 - $17.65 $626,661 - $778,364	-44,100 Reduced 9.89%	401,600 $5.77 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $1.19 Million - $2.16 Million	125,100 Added 39.02%	445,700 $7.05 Million
Q1 2021 May 18, 2021	BUY	$7.37 - $13.61 $1.7 Million - $3.13 Million	230,200 Added 254.65%	320,600 $3.26 Million
Q4 2020 Feb 17, 2021	BUY	$3.37 - $8.61 $84,924 - $216,972	25,200 Added 38.65%	90,400 $673,000
Q3 2020 Nov 17, 2020	BUY	$3.43 - $5.53 $223,636 - $360,556	65,200 New	65,200 $224,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.